.webp&w=828&q=75)
Learn how the P/E ratio helps investors value ASX stocks, compare companies, identify potential opportunities, and understand why a low or high P/E does not always mean a stock is cheap or expensive.
.webp&w=828&q=75)
Meteoric Resources (ASX: MEI) delivers a robust DFS for its Caldeira Rare Earth Project, confirming Tier‑1 scale, low‑cost production, and strategic positioning in global rare‑earth supply chains.
.webp&w=828&q=75)
Learn how franking credits and fully franked dividends work for ASX investors, including tax offsets, dividend yields, the 45-day holding rule, and what to check before choosing Australian dividend stocks.
.webp&w=828&q=75)
Bapcor’s FY26 turnaround shows improving sales momentum, lower debt, tighter pricing controls and stronger stock availability, though weak earnings, execution risks and cost pressures mean the recovery still needs further proof.
.webp&w=828&q=75)
Learn how to identify undervalued ASX stocks using seven key valuation metrics, including P/E, price-to-book, EV/EBITDA, PEG, free cash flow yield and dividend yield, while spotting potential value traps before making an investment decision.

Objective Corporation delivered higher FY2026 revenue and earnings, but lost contracts, weaker recurring revenue and a softer FY2027 outlook have shifted attention toward whether AI, government software and new projects can restore growth.
.webp&w=828&q=75)
Tribune Resources (ASX: TBR) demonstrates disciplined operations and resilient cash generation through its East Kundana Joint Venture (EKJV) with Evolution Mining, maintaining strong production and resource confidence amid cost pressures and market volatility.
.webp&w=828&q=75)
X2M Connect is expanding beyond smart metering into AI-enabled data centres, energy management and infrastructure services. A binding A$250 million-plus AI data centre agreement and new Seoul contracts boost growth potential, but execution, approvals, funding and profitability remain key risks.

Revenue and EPS are expected to grow through FY27–FY28, although earnings remain sensitive to gold prices and mining costs. Based on FY26 normalised EPS of A$0.76 and a 10–12x P/E, fair value is estimated at A$7.6–9.1 per share.
.webp&w=828&q=75)
Golden Deeps is advancing deeper drilling at Graceland after encouraging copper, silver and zinc results. Fresh assays and new targets have strengthened interest in the Namibian exploration program, while upcoming drilling will test the discovery’s potential scale.

Learn what market capitalisation means, how ASX market cap is calculated, and the key differences between small-, mid-, and large-cap stocks when comparing Australian-listed companies.

IGO (ASX: IGO) delivers strong FY26 results with disciplined execution, expanding margins at Greenbushes and Nova, and strategic portfolio optimisation aligned with global energy transition.

AVITA Medical is strengthening its commercial position as revenue growth improves, cash burn reduces, and its regenerative medicine portfolio expands. The company’s progress in product adoption and operational efficiency keeps it positioned as a speculative healthcare growth story.
.webp&w=828&q=75)
Learn the key differences between the ASX 200 and All Ordinaries, including company coverage, investment uses, and how each index helps investors understand the Australian share market.
.webp&w=828&q=75)
Bannerman Energy (ASX: BMN) advances Etango uranium project with CNNC financing, strong early works execution, and rising uranium prices, positioning as a leveraged mid-cap growth play in a buoyant nuclear fuel market.
.webp&w=828&q=75)
Felix Gold is advancing Alaskan antimony and gold assets, with potential US$18 million DOE pilot-processing funding driving investor interest. The non-dilutive funding could support domestic antimony supply, though project execution, permitting and financing risks remain.

Pro Medicus (ASX: PME) delivers record revenue growth, expanding margins, and accelerating AI‑driven innovation, reinforcing its global leadership in enterprise imaging and cloud‑based diagnostics.
.webp&w=828&q=75)
BlinkLab (ASX: BB1) is advancing its autism and ADHD assessment technology through clinical studies, FDA validation work, and research partnerships. Recent technical strength reflects growing investor interest, though regulatory and commercial risks remain.

EQT Holdings (ASX: EQT) delivers strong margin expansion, organic growth and robust cash generation across its trustee service lines, while navigating regulatory headwinds with discipline and strategic clarity.

Life360 delivers powerful subscription and advertising growth, expanding margins and accelerating global penetration. Strong MAU momentum, rising Paying Circles, and a breakout technical setup reinforce the company’s position as a high‑growth digital safety leader.
.webp&w=828&q=75)
Locksley Resources faces investor pressure after pausing Mojave exploration activities. The company is reassessing project spending, focusing on preserving assets, and reviewing future opportunities across its critical minerals portfolio.